Survivorship care for patients curatively treated for Hodgkin's and non-Hodgkin's lymphoma: a scoping review

M Powis, S Hack, R Fazelzad, D Hodgson… - Journal of Cancer …, 2023 - Springer
Purpose We undertook a scoping review of the literature to synthesize what is known about
lymphoma survivorship and develop a comprehensive set of lymphoma-specific survivorship …

[HTML][HTML] Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of …

K Smeland, H Holte, UM Fagerli, H Bersvendsen… - …, 2022 - ncbi.nlm.nih.gov
Lymphoma survivors after high-dose therapy with autologous stem-cell transplant (HDT-
ASCT) are at risk of several late effects, which might impair their health-related quality of life …

The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study

MA Pedersen, LC Gormsen… - British Journal of …, 2024 - Wiley Online Library
Standard CHOP treatment includes a high cumulative dose of prednisone, and studies have
shown increased fracture risk following CHOP. It is unclear whether reductions in bone …

A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment

P Jensen, LH Jakobsen, M Bøgsted, J Baech… - Blood …, 2022 - ashpublications.org
Lymphoma patients often receive high glucocorticoid doses as part of standard therapy.
Observational studies have shown a substantial risk of glucocorticoid-induced osteoporosis …

Low bone mineral density and high bone turnover in patients with Non-Hodgkin's Lymphoma (NHL) who receive frontline therapy: results of a multicenter prospective …

K Anargyrou, D Fotiou, TP Vassilakopoulos… - …, 2019 - journals.lww.com
Chemotherapy associated osteoporosis is a severe problem in patients with malignant
diseases as it increases the risk for fractures and deteriorates quality of life. There are very …

Факторы, влияющие на ремоделирование костной ткани, у больных лимфомой Ходжкина (обзор литературы)

МС Войтко, ТИ Поспелова, ВВ Климонтов… - Сибирский научный …, 2018 - cyberleninka.ru
В настоящее время лимфома Ходжкина признана потенциально излечимым
заболеванием, при применении современных программ химиотерапии могут быть …

Increased risk of hip fracture in patients with lymphoma, a Swedish population study of 37,236 lymphoma patients

P Johansson, H Lind Kristjansdottir… - Calcified Tissue …, 2020 - Springer
Increased bone loss has been noted in lymphoma patients; however, the incidence of hip
fracture is not known. The aim of our study was to explore the risk for hip fracture in patients …

Osteometabolic changes in patients under antineoplastic treatment: scoping review

LDA Rezende, D de Souza Catabriga… - Health Sciences …, 2023 - portalrcs.hcitajuba.org.br
Objective: To summarize the main evidence regarding osteometabolic changes in patients
undergoing antineoplastic treatment. Methods: This is a scoping review, following the …

Blood and Bone-Epidemiological studies on the association between blood and bone

HL Kristjansdottir - 2021 - gupea.ub.gu.se
Introduction: Preclinical and clinical studies have suggested that blood-and bone cells are
interconnected. Aims: To study the association between hematological variables, specifically …

[HTML][HTML] FACTORS AFFECTING BONE REMODELING IN PATIENTS WITH HODGKIN'S LYMPHOMA

MS Voytko, TI Pospelova, VV Klimontov… - Сибирский научный …, 2018 - sibmed.elpub.ru
Hodgkin's lymphoma is considered a potentially curable disease. Chemotherapy-based
salvage regimens can achieve responses in 90% of patients with Hodgkin's lymphoma. The …